Reduced Contraction of Blood Clots in Venous Thromboembolism Is a Potential Thrombogenic and Embologenic Mechanism

Abstract

Contraction (retraction) of the blood clot is a part of the clotting process driven by activated platelets attached to fibrin that can potentially modulate the obstructiveness and integrity of thrombi. The aim of this work was to reveal the pathogenic importance of contraction of clots and thrombi in venous thromboembolism (VTE). We investigated the kinetics of clot contraction in the blood of 55 patients with VTE. In addition, we studied the ultrastructure of ex vivo venous thrombi as well as the morphology and functionality of isolated platelets. Thrombi from VTE patients contained compressed polyhedral erythrocytes, a marker for clot contraction in vivo. The extent and rate of contraction were reduced by twofold in clots from the blood of VTE patients compared with healthy controls. The contraction of clots from the blood of patients with pulmonary embolism was significantly impaired compared with that of those with isolated venous thrombosis, suggesting that less compacted thrombi are prone to embolization. The reduced ability of clots to contract correlated with continuous platelet activation followed by their partial refractoriness. Morphologically, 75% of platelets from VTE patients were spontaneously activated (with filopodia) compared with only 21% from healthy controls. At the same time, platelets from VTE patients showed a 1.4-fold reduction in activation markers expressed in response to chemical activation when compared with healthy individuals. The results obtained suggest that the impaired contraction of thrombi is an underappreciated pathogenic mechanism in VTE that may regulate the obstructiveness and embologenicity of venous thrombi.

Keywords

blood clotting - thrombosis - clot contraction - clot retraction - venous thromboembolism

• References

• 1 Roger VL, Go AS, Lloyd-Jones DM. , et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 2012; 125 (01) e2-e220
• 2 Bing R, Chow V, Lau JK, Thomas L, Kritharides L, Ng ACC. Prevalence of echocardiography use in patients hospitalized with confirmed acute pulmonary embolism: a real-world observational multicenter study. PLoS One 2016; 11 (12) e0168554
• 3 Lee JS, Moon T, Kim TH. , et al. Deep vein thrombosis in patients with pulmonary embolism: prevalence, clinical significance and outcome. Vasc Spec Int 2016; 32 (04) 166-174
• 4 Wolberg AS. Primed to understand fibrinogen in cardiovascular disease. Arterioscler Thromb Vasc Biol 2016; 36 (01) 4-6
• 5 Geddings JE, Mackman N. Recently identified factors that regulate hemostasis and thrombosis. Thromb Haemost 2014; 111 (04) 570-574
• 6 Byrnes JR, Wolberg AS. New findings on venous thrombogenesis. Hamostaseologie 2017; 37 (01) 25-35
• 7 Wolberg AS, Aleman MM, Leiderman K, Machlus KR. Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited. Anesth Analg 2012; 114 (02) 275-285
• 8 von Brühl ML, Stark K, Steinhart A. , et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209 (04) 819-835
• 9 Heestermans M, Salloum-Asfar S, Salvatori D. , et al. Role of platelets, neutrophils, and factor XII in spontaneous venous thrombosis in mice. Blood 2016; 127 (21) 2630-2637
• 10 Walton BL, Byrnes JR, Wolberg AS. Fibrinogen, red blood cells, and factor XIII in venous thrombosis. J Thromb Haemost 2015; 13 (Suppl. 01) S208-S215
• 11 Wakefield TW, Strieter RM, Wilke CA. , et al. Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 1995; 15 (02) 258-268
• 12 Cines DB, Lebedeva T, Nagaswami C. , et al. Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin. Blood 2014; 123 (10) 1596-1603
• 13 Tutwiler V, Litvinov RI, Lozhkin AP. , et al. Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood. Blood 2016; 127 (01) 149-159
• 14 Carr Jr ME. Development of platelet contractile force as a research and clinical measure of platelet function. Cell Biochem Biophys 2003; 38 (01) 55-78
• 15 Litvinov RI, Weisel JW. What is the biological and clinical relevance of fibrin?. Semin Thromb Hemost 2016; 42 (04) 333-343
• 16 Kim OV, Litvinov RI, Alber MS, Weisel JW. Quantitative structural mechanobiology of platelet-driven blood clot contraction. Nat Commun 2017; 8 (01) 1274
• 17 Muthard RW, Diamond SL. Blood clots are rapidly assembled hemodynamic sensors: flow arrest triggers intraluminal thrombus contraction. Arterioscler Thromb Vasc Biol 2012; 32 (12) 2938-2945
• 18 Tutwiler V, Peshkova AD, Andrianova IA, Khasanova DR, Weisel JW, Litvinov RI. Contraction of blood clots is impaired in ischemic stroke. Arterioscler Thromb Vasc Biol 2017; 37 (02) 271-279
• 19 Dashkevich NM, Vuimo TA, Ovsepyan RA. , et al. Effect of pre-analytical conditions on the thrombodynamics assay. Thromb Res 2014; 133 (03) 472-476
• 20 Savelyev VS, Chazov EI, Gusev EI. , et al. Russian clinical recommendations for the diagnostics, treatment, and prophylaxis of venous thromboembolism. Phlebologie 2010; 4 (1–2): 2-37
• 21 Ząbczyk M, Sadowski M, Zalewski J, Undas A. Polyhedrocytes in intracoronary thrombi from patients with ST-elevation myocardial infarction. Int J Cardiol 2015; 179: 186-187
• 22 Leong L, Chernysh IN, Xu Y. , et al. Clot stability as a determinant of effective factor VIII replacement in hemophilia A. Res Pract Thromb Haemost 2017; 1 (02) 231-241
• 23 Litvinov RI, Khismatullin RR, Shakirova AZ. , et al. Morphological signs of intravital contraction (retraction) of pulmonary thrombotic emboli. BioNanoScience 2017;
• 24 Blumenberg RM, Barton E, Gelfand ML, Skudder P, Brennan J. Occult deep venous thrombosis complicating superficial thrombophlebitis. J Vasc Surg 1998; 27 (02) 338-343
• 25 Peshkova AD, Le Minh G, Tutwiler V, Andrianova IA, Weisel JW, Litvinov RI. Activated monocytes enhance platelet-driven contraction of blood clots via tissue factor expression. Sci Rep 2017; 7 (01) 5149
• 26 Jurk K, Jahn UR, Van Aken H. , et al. Platelets in patients with acute ischemic stroke are exhausted and refractory to thrombin, due to cleavage of the seven-transmembrane thrombin receptor (PAR-1). Thromb Haemost 2004; 91 (02) 334-344
• 27 Greilich PE, Brouse CF, Beckham J, Jessen ME, Martin EJ, Carr ME. Reductions in platelet contractile force correlate with duration of cardiopulmonary bypass and blood loss in patients undergoing cardiac surgery. Thromb Res 2002; 105 (06) 523-529
• 28 Lam WA, Chaudhuri O, Crow A. , et al. Mechanics and contraction dynamics of single platelets and implications for clot stiffening. Nat Mater 2011; 10 (01) 61-66
• 29 Niederman R, Pollard TD. Human platelet myosin. II. In vitro assembly and structure of myosin filaments. J Cell Biol 1975; 67 (01) 72-92
• 30 Ehrlicher A, Hartwig JH. Cell mechanics: contracting to stiffness. Nat Mater 2011; 10 (01) 12-13
• 31 Wufsus AR, Rana K, Brown A, Dorgan JR, Liberatore MW, Neeves KB. Elastic behavior and platelet retraction in low- and high-density fibrin gels. Biophys J 2015; 108 (01) 173-183